We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Image: Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group, expanding the company’s pathology portfolio across clinical and research settings

Agilent Strengthens Pathology Capabilities Through Biocare Acquisition

Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group, expanding its clinical and research pathology portfolio. More...
29 Jun 2026
Image: The planned Bio-Techne acquisition would strengthen Merck KGaA, Darmstadt, Germany, in multi-omics, spatial biology, cell and gene therapy, precision diagnostics, and research tools.

Merck KGaA to Acquire Bio-Techne, Expanding Life Science Portfolio

Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in fast-growing life sciences markets. More...
29 Jun 2026
Image: a new initiative aims to bring greater precision to this class of therapeutics (Photo courtesy of One Biosciences)

Project Aims to Develop First Single-Cell Assay for ADC Therapies

One Biosciences receives Paris Saclay Cancer Cluster BOOST funding to advance a single-cell assay approach for antibody-drug conjugate therapies. More...
26 Jun 2026
Image: The proposed immunoassay uses ALZpath’s pTau217 antibody to detect Alzheimer’s disease biology in blood, supporting the growing role of blood-based biomarkers in clinical care (Photo courtesy of Shutterstock)

Agreement Supports pTau217-Based Alzheimer’s Blood Test Development

ALZpath is licensing its proprietary pTau217 antibody to Abbott for development of an Alzheimer’s disease IVD test. More...
26 Jun 2026
Image: Volition’s Nu.Q NETs test detects markers associated with neutrophil extracellular traps, which are released during NETosis and linked to sepsis and other acute and chronic disorders (Image credit: iStock)

Collaboration Aims to Broaden Access to NETosis-Linked Disease Testing

VolitionRx announced a collaboration with Sysmex Corporation to optimize Volition’s Nu.Q NETs H3.1 assay on the Sysmex platform.  More...
25 Jun 2026
Image: At the core of the collaboration is Pirche’s TxPredictor platform, which uses proprietary algorithms to analyze histocompatibility and predict immunological risk (Photo courtesy of Pirche AG)

Partnership Aims to Improve Transplant Monitoring Across Care Continuum

A new partnership links pre-transplant molecular risk stratification with post-transplant dd-cfDNA monitoring. More...
24 Jun 2026
Photo courtesy of Qiagen

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

New dPCR tools add gene expression assays, 12-plex RNA detection, and automated reporting to standardize biopharma workflows. More...
17 Jun 2026
Visit expo >
Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Steam Sterilizer
Hi Vac II Line
Thyroid Test
Anti-Thyroid EIA Test

In Other News



LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000 - 2026 Globetech Media.
All rights reserved.
ADLM